5-HT1A therapeutics (New York University)

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug Name5-HT1A therapeutics (New York University)
Drug Alias Name5-HT1A antagonists (New York University)S-100B derivatives5-HT1A agonists (New York University)S-100B
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin 1a (5-HT1a) receptor agonistsSerotonin 1a (5-HT1a) receptor antagonists
TargetsSerotonin 1a (5-HT1a) receptor
Therapy Area/IndicationsNerve DegenerationNervous System Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNew York University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNew York University
Active IndicationsN/A
Inactive IndicationsNerve DegenerationNervous System Diseases

Other Information

ATC CodeN/A
Related LinksN/A